Skip to Content
Søg Menu

Low-dose Decitabine/Cedazuridine Reduces Toxicity While Preserving Efficacy in Low-risk MDS

/ Jan Andreasen
ASH25
Signe Modvig

Danish Research Identifies Promising New Target for Preventing CNS Relapse in ALL

/ Signe Modvig
ASH25 Play the Video

BPd Preserved or Improved Quality of Life in Patients with RRMM

/ Paul G. Richardson / Jan Andreasen
ASH25Myelomatose
Ingrid Cecilia Glimelius

Novel Clinical Data in Mantle Cell Lymphoma Highlighted in ASH 2025 Oral Session

/ Ingrid Cecilia Glimelius
ASH25 Play the Video
Ingrid Cecilia Glimelius

Nordic Study Uncovers a New Minimally Invasive Biomarker for Low-Risk Mantle Cell Lymphoma

/ Ingrid Cecilia Glimelius
ASH25 Play the Video
Henrik Hjorth-Hansen

Improving CML Outcomes: Nordic CML Study Group Shares New ASH 2025 Insights

/ Henrik Hjorth-Hansen
ASH25Lymfom Play the Video
Wojciech Jurczak

Pirtobrutinib Showed Positive Efficacy and Safety vs Ibrutinib in BTKi-naïve CLL/SLL Patients Both for Treatment-naïve Patients and Patients with R/R Disease

/ Wojciech Jurczak
ASH25CLL Play the Video
Waleed Ghanima

Norwegian Study Can Change the Clinical Practice for Patients with Immune Thrombocytopenia

/ Waleed Ghanima
ASH25 Play the Video
Jelena Jelicic

Danish Study Finds That Variability in Eligibility Criteria Hampers Comparability of Frontline DLBCL Trials

/ Jelena Jelicic
ASH25Lymfom Play the Video
Astrid Hundeboell Torpe

ASH 2025: Prophylactic Tocilizumab Reduces CRS

/ Astrid Hundebøll Torpe
ASH25Multiple myeloma Play the Video

Top Abstract Spotlight: Menin Inhibitors are a Game Changer for the Treatment of Patients with Newly Diagnosed AML 

/ Jan Andreasen
ASH25AML

Fixed-Duration Venetoclax Regimens Match Continuous BTKi in Frontline CLL

/ Jan Andreasen
ASH25CLL
Back to top